Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies

Why is Trump imposing 35% tariffs on Canadian goods? How did Nvidia reach a $4 trillion market cap? What caused Bitcoin’s price to hit new highs? Why is Ford recalling over 850,000 cars now? How are AI layoffs affecting job platforms like Indeed? What impact will Trump’s Brazil tariffs have on coffee prices? Why is the US sending weapons to Ukraine via NATO allies?

Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies

benzinga.com/markets/equities/25/07/46364024/trump-threatens-200-pharma-tariffs-but-analyst-says-this-stock-is-immune-and-expected-to-benefit

While President Donald Trump's proposed 200% tariffs on pharmaceutical imports could potentially squeeze the profit margins, this stock is poised to “benefit” from the levies.
What Happened: Trump announced on Tuesday that the pharma tariffs, part of a Section 232 investigation launched…

This story appeared on benzinga.com, 2025-07-11 11:57:43.